{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T12:34:04Z","timestamp":1792758844502,"version":"4.5.0"},"reference-count":58,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2004,11,1]],"date-time":"2004-11-01T00:00:00Z","timestamp":1099267200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Joint Bone Spine"],"published-print":{"date-parts":[[2004,11]]},"DOI":"10.1016\/j.jbspin.2004.03.004","type":"journal-article","created":{"date-parts":[[2004,5,15]],"date-time":"2004-05-15T10:35:42Z","timestamp":1084617342000},"page":"503-510","source":"Crossref","is-referenced-by-count":60,"title":["Signal transduction pathways: new targets for treating rheumatoid arthritis"],"prefix":"10.1016","volume":"71","author":[{"given":"Jacques","family":"Morel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis","family":"Berenbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbspin.2004.03.004_BIB1","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1053\/berh.2001.0194","article-title":"Signal transduction in rheumatoid arthritis","volume":"15","author":"Piecyk","year":"2001","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.jbspin.2004.03.004_BIB2","doi-asserted-by":"crossref","first-page":"891","DOI":"10.2165\/00003495-200262060-00003","article-title":"Newer immunosuppressive drugs: their potential role in rheumatoid arthritis therapy","volume":"62","author":"Drosos","year":"2002","journal-title":"Drugs"},{"key":"10.1016\/j.jbspin.2004.03.004_BIB3","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/S0167-5699(97)01197-3","article-title":"Signal transduction through NF-kappaB","volume":"19","author":"May","year":"1998","journal-title":"Immunol Today"},{"key":"10.1016\/j.jbspin.2004.03.004_BIB4","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1172\/JCI11830","article-title":"NF-kappaB: a key role in inflammatory diseases","volume":"107","author":"Tak","year":"2001","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jbspin.2004.03.004_BIB5","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1006\/excr.1999.4733","article-title":"Tumor necrosis factor receptor-associated factor (TRAF) family: adapter proteins that mediate cytokine signaling","volume":"254","author":"Inoue","year":"2000","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.jbspin.2004.03.004_BIB6","doi-asserted-by":"crossref","first-page":"7420","DOI":"10.1074\/jbc.270.13.7420","article-title":"Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine","volume":"270","author":"Raingeaud","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jbspin.2004.03.004_BIB7","first-page":"124","article-title":"Jun N-terminal kinase in rheumatoid arthritis","volume":"291","author":"Han","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jbspin.2004.03.004_BIB8","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0014-5793(95)00346-B","article-title":"Activation of the MAP kinase homologue RK requires the phosphorylation of Thr-180 and Tyr-182 and both residues are phosphorylated in chemically stressed KB cells","volume":"364","author":"Doza","year":"1995","journal-title":"FEBS Lett"},{"key":"10.1016\/j.jbspin.2004.03.004_BIB9","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S1357-4310(99)01544-0","article-title":"p38 MAPK signalling cascades in inflammatory disease","volume":"5","author":"Herlaar","year":"1999","journal-title":"Mol Med Today"},{"key":"10.1016\/j.jbspin.2004.03.004_BIB10","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1091\/mbc.10.6.1693","article-title":"Transformation by v-Src: Ras-MAPK and PI3K-mTOR mediate parallel pathways","volume":"10","author":"Penuel","year":"1999","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.jbspin.2004.03.004_BIB11","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/1529-0131(199904)42:4<609::AID-ANR3>3.0.CO;2-I","article-title":"Signal transduction and transcription factors in rheumatic disease","volume":"42","author":"Firestein","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2004.03.004_BIB12","first-page":"129","article-title":"The role of jun, fos and the AP-1 complex in cell-proliferation and transformation","volume":"1072","author":"Angel","year":"1991","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jbspin.2004.03.004_BIB13","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1126\/science.7839144","article-title":"Independent human MAP-kinase signal transduction pathways defined by MEK and MKK isoforms","volume":"267","author":"Derijard","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.jbspin.2004.03.004_BIB14","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S1297-319X(00)00212-8","article-title":"Proinflammatory cytokines, prostaglandins, and the chondrocyte: mechanisms of intracellular activation","volume":"67","author":"Berenbaum","year":"2000","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jbspin.2004.03.004_BIB15","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1042\/0264-6021:3620367","article-title":"Differentiation regulates interleukin-1beta-induced cyclo-oxygenase-2 in human articular chondrocytes: role of p38 mitogen-activated protein kinase","volume":"362","author":"Thomas","year":"2002","journal-title":"Biochem J"},{"key":"10.1016\/j.jbspin.2004.03.004_BIB16","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0014-5793(98)00226-9","article-title":"TRAF2 plays a dual role in NF-kappaB-dependent gene activation by mediating the TNF-induced activation of p38 MAPK and I-kappaB kinase pathways","volume":"425","author":"Carpentier","year":"1998","journal-title":"FEBS Lett"},{"key":"10.1016\/j.jbspin.2004.03.004_BIB17","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1002\/1529-0131(200011)43:11<2501::AID-ANR18>3.0.CO;2-K","article-title":"Activation, differential localization, and regulation of the stress-activated protein kinases, extracellular signal-regulated kinase, c-jun N-terminal kinase, and p38 mitogen-activated protein kinase, in synovial tissue and cells in rheumatoid arthritis","volume":"43","author":"Schett","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2004.03.004_BIB18","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0014-5793(99)01717-2","article-title":"The role of p38 mitogen-activated protein kinase in IL-6 and IL-8 production from the TNF-alpha- or IL-1beta-stimulated rheumatoid synovial fibroblasts","volume":"465","author":"Suzuki","year":"2000","journal-title":"FEBS Lett"},{"key":"10.1016\/j.jbspin.2004.03.004_BIB19","doi-asserted-by":"crossref","first-page":"24832","DOI":"10.1074\/jbc.273.38.24832","article-title":"Regulation of interleukin-1beta-induced interleukin-6 gene expression in human fibroblast-like synoviocytes by p38 mitogen-activated protein kinase","volume":"273","author":"Miyazawa","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jbspin.2004.03.004_BIB20","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1002\/j.1460-2075.1996.tb00542.x","article-title":"The p38\/RK mitogen-activated protein kinase pathway regulates interleukin-6 synthesis response to tumor necrosis factor","volume":"15","author":"Beyaert","year":"1996","journal-title":"EMBO J"},{"key":"10.1016\/j.jbspin.2004.03.004_BIB21","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/372739a0","article-title":"A protein kinase involved in the regulation of inflammatory cytokine biosynthesis","volume":"372","author":"Lee","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.jbspin.2004.03.004_BIB22","doi-asserted-by":"crossref","first-page":"4969","DOI":"10.1093\/emboj\/18.18.4969","article-title":"The p38 MAP kinase pathway signals for cytokine-induced mRNA stabilization via MAP kinase-activated protein kinase 2\u00a0and an AU-rich region-targeted mechanism","volume":"18","author":"Winzen","year":"1999","journal-title":"EMBO J"},{"key":"10.1016\/j.jbspin.2004.03.004_BIB23","doi-asserted-by":"crossref","first-page":"13680","DOI":"10.1074\/jbc.M211570200","article-title":"Concomitant recruitment of ERK1\/2\u00a0and p38 MAPK signalling pathway is required for activation of cytoplasmic phospholipase A2 via ATP in articular chondrocytes","volume":"278","author":"Berenbaum","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jbspin.2004.03.004_BIB24","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1126\/science.296.5573.1655","article-title":"The phosphoinositide 3-kinase pathway","volume":"296","author":"Cantley","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.jbspin.2004.03.004_BIB25","doi-asserted-by":"crossref","first-page":"29167","DOI":"10.1074\/jbc.272.46.29167","article-title":"Phosphatidylinositol 3-kinase in interleukin 1\u00a0signaling. Physical interaction with the interleukin 1\u00a0receptor and requirement in NF-kappaB and AP-1 activation","volume":"272","author":"Reddy","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jbspin.2004.03.004_BIB26","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.4049\/jimmunol.164.3.1355","article-title":"Phosphatidylinositol 3-kinase as a mediator of TNF-induced NF-kappaB activation","volume":"164","author":"Reddy","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.jbspin.2004.03.004_BIB27","doi-asserted-by":"crossref","first-page":"34679","DOI":"10.1074\/jbc.M206337200","article-title":"Signal transduction pathways involved in rheumatoid arthritis synovial fibroblast interleukin-18-induced vascular cell adhesion molecule-1 expression","volume":"277","author":"Morel","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jbspin.2004.03.004_BIB28","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/35077225","article-title":"Oncogenic kinase signalling","volume":"411","author":"Blume-Jensen","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.jbspin.2004.03.004_BIB29","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1046\/j.1432-1327.2001.01936.x","article-title":"Phosphatidylinositol 3-kinases in tumor progression","volume":"268","author":"Roymans","year":"2001","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.jbspin.2004.03.004_BIB30","doi-asserted-by":"crossref","first-page":"37069","DOI":"10.1074\/jbc.M103574200","article-title":"A novel role for interleukin-18 in adhesion molecule induction through NF-kappaB and phosphatidylinositol (PI) 3-kinase-dependent signal transduction pathways","volume":"276","author":"Morel","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jbspin.2004.03.004_BIB31","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/1529-0131(200201)46:1<31::AID-ART10029>3.0.CO;2-5","article-title":"Evidence that rheumatoid arthritis synovial T cells are similar to cytokine-activated T cells: involvement of phosphatidylinositol 3-kinase and nuclear factor kappaB pathways in tumor necrosis factor alpha production in rheumatoid arthritis","volume":"46","author":"Brennan","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2004.03.004_BIB32","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1126\/science.1071545","article-title":"A road map for those who know Jak-STAT","volume":"296","author":"Aaronson","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.jbspin.2004.03.004_BIB33","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1172\/JCI13568","article-title":"Induction of the cytokine signal regulator SOCS3\/CIS3 as a therapeutic strategy for treating inflammatory arthritis","volume":"108","author":"Shouda","year":"2001","journal-title":"J Clin Invest"},{"issue":"Suppl 2","key":"10.1016\/j.jbspin.2004.03.004_BIB34","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/BF03165116","article-title":"Treatment of chronic myeloid leukaemia: lessons and challenges","volume":"76","author":"Goldman","year":"2002","journal-title":"Int J Hematol"},{"key":"10.1016\/j.jbspin.2004.03.004_BIB35","first-page":"680","article-title":"RWJ 67657, a potent, orally active inhibitor of p38 mitogen-activated protein kinase","volume":"291","author":"Wadsworth","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jbspin.2004.03.004_BIB36","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0968-0896(00)00331-X","article-title":"The discovery of RPR 200765A, a p38 MAP kinase inhibitor displaying a good oral anti-arthritic efficacy","volume":"9","author":"McLay","year":"2001","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.jbspin.2004.03.004_BIB37","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1046\/j.1365-2249.2001.01485.x","article-title":"Suppression of the clinical and cytokine response to endotoxin by RWJ 67657, a p38 mitogen-activated protein-kinase inhibitor, in healthy human volunteers","volume":"124","author":"Fijen","year":"2001","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jbspin.2004.03.004_BIB38","first-page":"166","article-title":"A double blind, placebo-controlled trial of VX-745, an oral p38 mitogen-activated protein kinase (MAPK) inhibitor in patients with rheumatoid arthritis","volume":"61","author":"Weisman","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2004.03.004_BIB39","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1172\/JCI12466","article-title":"c-jun N-terminal kinase is required for metalloproteinase expression and joint destruction in inflammatory arthritis","volume":"108","author":"Han","year":"2001","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jbspin.2004.03.004_BIB40","doi-asserted-by":"crossref","first-page":"9579","DOI":"10.1021\/bi972914c","article-title":"Ro 09-2210 exhibits potent anti-proliferative effects on activated T cells by selectively blocking MKK activity","volume":"37","author":"Williams","year":"1998","journal-title":"Biochemistry"},{"issue":"Suppl 1","key":"10.1016\/j.jbspin.2004.03.004_BIB41","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0305-7372(03)00080-X","article-title":"Clinical update: proteasome inhibitors in hematologic malignancies","volume":"29","author":"Richardson","year":"2003","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.jbspin.2004.03.004_BIB42","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.1002\/art.11131","article-title":"A highly selective inhibitor of I-kappaB kinase, BMS-345541, blocks both joint inflammation and destruction in collagen-induced arthritis in mice","volume":"48","author":"McIntyre","year":"2003","journal-title":"Arthritis Rheum"},{"issue":"Suppl 2","key":"10.1016\/j.jbspin.2004.03.004_BIB43","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1136\/ard.61.suppl_2.ii13","article-title":"Is NF-kappaB a useful therapeutic target in rheumatoid arthritis?","volume":"61","author":"Feldmann","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2004.03.004_BIB44","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/10577","article-title":"Control of inducible chemoresistance: enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-kappaB","volume":"5","author":"Wang","year":"1999","journal-title":"Nat Med"},{"key":"10.1016\/j.jbspin.2004.03.004_BIB45","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1002\/1529-0131(200108)44:8<1897::AID-ART328>3.0.CO;2-4","article-title":"Inhibitor of nuclear factor kappaB kinase beta is a key regulator of synovial inflammation","volume":"44","author":"Tak","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2004.03.004_BIB46","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0092-8674(00)80674-1","article-title":"The multiple roles of PTEN in tumor suppression","volume":"100","author":"Di Cristofano","year":"2000","journal-title":"Cell"},{"issue":"1027","key":"10.1016\/j.jbspin.2004.03.004_BIB47","first-page":"1029","article-title":"A surprising function for the PTEN tumor suppressor","volume":"282","author":"Hopkin","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.jbspin.2004.03.004_BIB48","doi-asserted-by":"crossref","first-page":"11402","DOI":"10.1074\/jbc.M007806200","article-title":"Tumor suppressor MMAC\/PTEN inhibits cytokine-induced NF-kappaB activation without interfering with the I-kappaB degradation pathway","volume":"276","author":"Koul","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jbspin.2004.03.004_BIB49","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1126\/science.285.5436.2122","article-title":"Impaired Fas response and autoimmunity in PTEN+\/\u2013 mice","volume":"285","author":"Di Cristofano","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.jbspin.2004.03.004_BIB50","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1002\/art.10314","article-title":"Necessary role of phosphatidylinositol 3-kinase in transforming growth factor beta-mediated activation of Akt in normal and rheumatoid arthritis synovial fibroblasts","volume":"46","author":"Kim","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2004.03.004_BIB51","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/ar69","article-title":"Activation of synovial fibroblasts in rheumatoid arthritis: lack of expression of the tumour suppressor PTEN at sites of invasive growth and destruction","volume":"2","author":"Pap","year":"2000","journal-title":"Arthritis Res"},{"key":"10.1016\/j.jbspin.2004.03.004_BIB52","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/43206","article-title":"A family of cytokine-inducible inhibitors of signalling","volume":"387","author":"Starr","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.jbspin.2004.03.004_BIB53","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1002\/art.11157","article-title":"Expression and regulation of intracellular SMAD signaling in scleroderma skin fibroblasts","volume":"48","author":"Mori","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2004.03.004_BIB54","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1749-6632.1998.tb11119.x","article-title":"Cytokine gene transcription by NF-kappaB family members in patients with inflammatory bowel disease","volume":"859","author":"Neurath","year":"1998","journal-title":"Ann New York Acad Sci"},{"key":"10.1016\/j.jbspin.2004.03.004_BIB55","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1038\/nm0996-998","article-title":"Local administration of anti-sense phosphorothioate oligonucleotides to the p65 subunit of NF-kappaB abrogates established experimental colitis in mice","volume":"2","author":"Neurath","year":"1996","journal-title":"Nat Med"},{"key":"10.1016\/j.jbspin.2004.03.004_BIB56","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1002\/1529-0131(199912)42:12<2532::AID-ANR5>3.0.CO;2-2","article-title":"Suppressed severity of collagen-induced arthritis by in vivo transfection of nuclear factor kappaB decoy oligodeoxynucleotides as a gene therapy","volume":"42","author":"Tomita","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2004.03.004_BIB57","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S0022-2836(03)00181-5","article-title":"Gene silencing by systemic delivery of synthetic siRNAs in adult mice","volume":"327","author":"Sorensen","year":"2003","journal-title":"J Mol Biol"},{"key":"10.1016\/j.jbspin.2004.03.004_BIB58","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0165-6147(97)01049-3","article-title":"Phosphodiesterase (PDE)4 inhibitors: anti-inflammatory drugs of the future?","volume":"18","author":"Teixeira","year":"1997","journal-title":"Trends Pharmacol Sci"}],"container-title":["Joint Bone Spine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X04000697?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X04000697?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,2]],"date-time":"2020-04-02T04:48:48Z","timestamp":1585802928000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1297319X04000697"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,11]]},"references-count":58,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2004,11]]}},"alternative-id":["S1297319X04000697"],"URL":"https:\/\/doi.org\/10.1016\/j.jbspin.2004.03.004","relation":{},"ISSN":["1297-319X"],"issn-type":[{"value":"1297-319X","type":"print"}],"subject":[],"published":{"date-parts":[[2004,11]]}}}